Rheonix Inc:企業の製品パイプライン分析2018

◆英語タイトル:Rheonix Inc - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12742
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rheonix Inc (Rheonix) is a medical equipment company that develops molecular diagnostic products. The company offers automated and integrated molecular testing device. It develops Rheonix CARD cartridge technology which penetrates molecular testing markets from diagnostics labs to applied markets testing for food and beverage applications and next-generation sequencing sample preparation. Rheonix also develops Encompass workstation products such as Encompass MDx and Encompass Optimum. The company’s Encompass Optimum workstation provides information per sample for food and beverage testing. Rheonix is headquartered in Ithaca, New York, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Rheonix Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Rheonix Inc Company Overview 5
Rheonix Inc Company Snapshot 5
Rheonix Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Rheonix Inc – Pipeline Analysis Overview 8
Rheonix Inc – Key Facts 8
Rheonix Inc – Major Products and Services 9
Rheonix Inc Pipeline Products by Development Stage 10
Rheonix Inc Pipeline Products Overview 12
Clopidogrel PGx Assay 12
Clopidogrel PGx Assay Product Overview 12
EncompassMDx Platform 13
EncompassMDx Platform Product Overview 13
GI CARD Assay 14
GI CARD Assay Product Overview 14
KRAS CARD Assay 15
KRAS CARD Assay Product Overview 15
Rheonix CARD – HIV Assay 16
Rheonix CARD – HIV Assay Product Overview 16
Rheonix CARD – Zika Virus Assay 17
Rheonix CARD – Zika Virus Assay Product Overview 17
Rheonix CARD HPV Assay 18
Rheonix CARD HPV Assay Product Overview 18
Rheonix CARD System 19
Rheonix CARD System Product Overview 19
Rheonix SeptiCARD Device 20
Rheonix SeptiCARD Device Product Overview 20
Rheonix STI(s) CARD Assay 21
Rheonix STI(s) CARD Assay Product Overview 21
UTI CARD Assay 22
UTI CARD Assay Product Overview 22
Warfarin PGx Assay 23
Warfarin PGx Assay Product Overview 23
Rheonix Inc – Key Competitors 24
Rheonix Inc – Key Employees 25
Rheonix Inc – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Rheonix Inc, Recent Developments 27
Feb 22, 2018: NYU Researchers Adapt HIV Test in Developing Rapid Diagnostic Test for Zika Virus 27
Apr 19, 2016: Rheonix To Pursue Rapid Zika Virus Diagnostic 28
Mar 10, 2016: Rheonix Develops Fully Automated Microfluidic System that Improves HIV Testing 29
Feb 10, 2015: Rheonix Receives $1.5 Million SBIR Phase II Grant from the National Institute of Dental & Craniofacial Research of the National Institutes of Health 29
Feb 10, 2015: Rheonix Receives $1.5 Million SBIR Phase II Grant from the National Institute of Dental and Craniofacial Research of the National Institutes of Health to Complete Development of a Rapid Point-of-Care Test for HIV/AIDS 30
Mar 24, 2014: Rheonix Invited to Present at ‘The Future of In-Vitro Diagnostics’ Conference hosted by Siemens 31
Jun 14, 2012: Rheonix Highlights First Fully Automated FFPE KRAS-Biomarker Assay At BIO International Convention 31
Dec 15, 2011: Rheonix Announces Novel Microarray Production Technology To Support Multiplexed Endpoint Detection Of SNPs On Rheonix CARD System 32
Nov 16, 2011: Rheonix Appoints Vice President Of Operations And Quality Manager 32
Jul 27, 2011: Rheonix Announces Positive Results Of New SeptiCARD For Detection Of Septicemia 32
Appendix 34
Methodology 34
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Rheonix Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Rheonix Inc Pipeline Products by Equipment Type 6
Rheonix Inc Pipeline Products by Indication 7
Rheonix Inc, Key Facts 8
Rheonix Inc, Major Products and Services 9
Rheonix Inc Number of Pipeline Products by Development Stage 10
Rheonix Inc Pipeline Products Summary by Development Stage 11
Clopidogrel PGx Assay - Product Status 12
Clopidogrel PGx Assay - Product Description 12
EncompassMDx Platform - Product Status 13
EncompassMDx Platform - Product Description 13
GI CARD Assay - Product Status 14
GI CARD Assay - Product Description 14
KRAS CARD Assay - Product Status 15
KRAS CARD Assay - Product Description 15
Rheonix CARD - HIV Assay - Product Status 16
Rheonix CARD - HIV Assay - Product Description 16
Rheonix CARD - Zika Virus Assay - Product Status 17
Rheonix CARD - Zika Virus Assay - Product Description 17
Rheonix CARD HPV Assay - Product Status 18
Rheonix CARD HPV Assay - Product Description 18
Rheonix CARD System - Product Status 19
Rheonix CARD System - Product Description 19
Rheonix SeptiCARD Device - Product Status 20
Rheonix SeptiCARD Device - Product Description 20
Rheonix STI(s) CARD Assay - Product Status 21
Rheonix STI(s) CARD Assay - Product Description 21
UTI CARD Assay - Product Status 22
UTI CARD Assay - Product Description 22
Warfarin PGx Assay - Product Status 23
Warfarin PGx Assay - Product Description 23
Rheonix Inc, Key Employees 25
Glossary 36

List of Figures
Rheonix Inc Pipeline Products by Equipment Type 6
Rheonix Inc Pipeline Products by Development Stage 10

★海外企業調査レポート[Rheonix Inc:企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Centrexion Therapeutics Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Centrexion Therapeutics Corp (Centrexion Therapeutics), formerly Centrexion Corp is a developer of clinical pipelines of novel and non opioid chronic pain therapy products. The company offers products such as CNTX-4975, CNTX- 0290, CNTX-6970, CNTX-2022, CNTX-6016 and Intrathecalplatform. Its …
  • Perenco Holdings:石油・ガス:M&Aディール及び事業提携情報
    Summary Perenco Holdings (Perenco) is an independent upstream energy company. It explores for, develops, produces, transports, and stores oil and gas. The company’s oil fields ranges from Northern Europe to Africa and Latin America to Southeast Asia. Through spot sales and long term sales agreements …
  • Zynerba Pharmaceuticals Inc (ZYNE):企業の財務・戦略的SWOT分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-euphoric cannabinoid, formulate …
  • juwi AG:企業の戦略的SWOT分析
    juwi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Vail Resorts Inc:企業の戦略・SWOT・財務情報
    Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Birdstep Technology ASA:企業のM&A・事業提携・投資動向
    Birdstep Technology ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Birdstep Technology ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Compugen Ltd (CGEN)-製薬・医療分野:企業M&A・提携分析
    Summary Compugen Ltd (Compugen) is a drug discovery company that develops medicines for immuno-oncology and autoimmune diseases. The company’s immuno-oncology pipeline comprises CGEN-15001T, CGEN-15022, CGEN-15022, CGEN-15029, target candidates, immuno-modulatory target candidates and ADC target can …
  • tella Inc (2191):製薬・医療:M&Aディール及び事業提携情報
    Summary Tella Inc (Tella) is a drug development company that develops vaccines for cancer treatment. The company offers dendritic cell vaccine therapy which develops dendritic cells to convey the information on cancer markers to lymphocytes and increase the dendritic cell population and strengthen t …
  • Techpool Bio-Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Techpool Bio-Pharma Co Ltd (Techpool Bio-Pharma) is a biopharmaceutical company. The company manufactures urinary protein biopharmaceuticals in critical care conditions. The company’s products include ulinastatin for injection, urinary kallidinogenase for injection, urokinase for injection a …
  • Daya Materials Bhd (DAYA):企業の財務・戦略的SWOT分析
    Summary Daya Materials Bhd (DMB) is a chemical company that offers polymer compound solutions. The company provides bulk chemicals, catalysts, additives, inert support materials and deodorizing agents. Its polymer compound products include semi conductive compounds, medium-voltage XLPE compounds, lo …
  • Habib Metropolitan Bank Limited:企業の戦略・SWOT・財務分析
    Habib Metropolitan Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Habib Metropolitan Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Akers Biosciences Inc (AKER):企業の財務・戦略的SWOT分析
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. ABI products include BreathScan alcohol detectors, CHUBE, METRO …
  • Suzuki Motor Corporation:企業の戦略・SWOT・財務分析
    Suzuki Motor Corporation - Strategy, SWOT and Corporate Finance Report Summary Suzuki Motor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Lendlease Corporation Limited (LLC):企業の財務・戦略的SWOT分析
    Lendlease Corporation Limited (LLC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Novelis Inc
    Novelis Inc - Strategy, SWOT and Corporate Finance Report Summary Novelis Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Impel NeuroPharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Impel NeuroPharma Inc (Impel) is a clinical-stage biotechnology company that which develops intranasal drug treatments for central nervous system disorders. The company’s product pipeline includes INP104, INP103, INP102, INP101, INP105, and INP106. It also develops Precision Olfactory Delive …
  • SeaBird Exploration PLC (SBX):企業の財務・戦略的SWOT分析
    Summary SeaBird Exploration PLC (SeaBird) operates as an oil and gas company that offers marine seismic data services. The company’s services include 2D seismic acquisition, 3D and 3D shallow water acquisition and source vessel. Its source vessels offers services such as conventional undershoots, 4d …
  • Huons Global Co Ltd (084110):企業の財務・戦略的SWOT分析
    Huons Global Co Ltd (084110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • McDermott International Inc (MDRIQ):企業の財務・戦略的SWOT分析
    McDermott International Inc (MDRIQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • AGL Energy Ltd (AGL):電力:M&Aディール及び事業提携情報
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆